An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

The single dose treatment helped patients lower “bad” cholesterol and triglyerides, both linked to heart disease ...

New Mexico health and environmental officials conducted a $1.2 million testing project, drawing blood from nearly 630 people.

Diabetologist Dr Arora emphasises the importance of 6 tests every 6 months for maintaining health as they aid in early ...

After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...

Creatine is a safe and effective supplement with very few side effects, unless taken at higher doses than recommended.

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

ALBUQUERQUE, N.M. (AP) — It’s a name many people have trouble pronouncing, but these synthetic chemicals have been used in everything from fast-food packaging to nonstick cookware, clothing, household ...

Vitamin D2 supplements may negatively impact circulating levels of vitamin D3 and negate the latter's potential benefits, according to a new meta-analysis.